These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane. Chow FL; Telen MJ; Rosse WF Blood; 1985 Oct; 66(4):940-5. PubMed ID: 4041621 [TBL] [Abstract][Full Text] [Related]
3. Paroxysmal nocturnal hemoglobinuria erythrocytes are of two distinct types: positive or negative for acetylcholinesterase. Dockter ME; Morrison M Blood; 1986 Feb; 67(2):540-3. PubMed ID: 3942836 [TBL] [Abstract][Full Text] [Related]
4. The mechanism of decreased red cell acetylcholinesterase activity in patients with paroxysmal nocturnal hemoglobinuria: Its relation to the membrane lipids. Shinohara K; Matsumoto N; Ishida Y; Kaneko T Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):25-9. PubMed ID: 6858569 [No Abstract] [Full Text] [Related]
5. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria. Chow FL; Hall SE; Rosse WF; Telen MJ Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235 [TBL] [Abstract][Full Text] [Related]
6. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Kunstling TR; Rosse WF Blood; 1969 Apr; 33(4):607-16. PubMed ID: 5776206 [No Abstract] [Full Text] [Related]
8. Relation between low erythrocyte acetylcholinesterase activity and membrane lipids in paroxysmal nocturnal haemoglobinuria. Siriwittayakorn J; Yuthavong Y Br J Haematol; 1979 Mar; 41(3):383-91. PubMed ID: 427042 [TBL] [Abstract][Full Text] [Related]
9. [Abnormalities of membrane-bound enzymes in red cell membrane disorders--special reference to acetylcholinesterase in paroxysmal nocturnal hemoglobinuria]. Shimoda M; Yawata Y Rinsho Ketsueki; 1986 Jul; 27(7):1145-59. PubMed ID: 3783997 [No Abstract] [Full Text] [Related]
10. Immunological assay of erythrocyte acetylcholinesterase. Jones JW; Whittaker M; Braven J Clin Chim Acta; 1991 Aug; 200(2-3):175-81. PubMed ID: 1777967 [TBL] [Abstract][Full Text] [Related]
11. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544 [TBL] [Abstract][Full Text] [Related]
17. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells). Ferrone S; Zanella A; Sirchia G Acta Vitaminol Enzymol; 1970; 24(6):222-5. PubMed ID: 5537936 [No Abstract] [Full Text] [Related]
18. Failure of in-vivo inhibition of acetylcholinesterase to affect erythrocyte life-span: the significance of the enzyme defect in paroxysmal nocturnal haemoglobinuria. METZ J; STEVENS K; VAN RENSBURG NJ; HART D Br J Haematol; 1961 Oct; 7():458-63. PubMed ID: 14473047 [No Abstract] [Full Text] [Related]
20. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9. Hänsch GM; Schönermark S; Roelcke D J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]